Concepedia

Publication | Open Access

Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease

25

Citations

24

References

2023

Year

Abstract

In this cohort of 4618 older patients with CKD, the 90-day risk of serious adverse events was higher among those who started low-dose methotrexate than those who started hydroxychloroquine. If verified, these risks should be balanced against the benefits of low-dose methotrexate use.

References

YearCitations

Page 1